In dogs with CE, we did not observe any significant association between mucosal S100A12 concentrations or MPO activities with CIBDAI scores before treatment or the clinical outcome in each intestinal segment (data not shown, p > 0.05). This evidence concerns the gene MPO and cholesteryl ester measurement.